Cartesian Therapeutics (RNAC) Q4 2024 Earnings

Nov 7Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-10.5
-6.82
-3.14
0.54

Details

Expected EPS
-0.801667
Actual EPS
-1.13
Surprise EPS
-0.33
Surprise Percent
-40.96%

Description

⁨Cartesian Therapeutics⁩ (⁦RNAC⁩) has reported earnings of ⁦-1.13⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts